Series D · Healthtech · Paris, France · Founded 2012 · 51–200 employees
Wandercraft pioneers intelligent, self-balancing robotic mobility systems designed to help walking-impaired individuals stand up and walk again. The company developed Atalante X, the world's first self-stabilizing, hands-free clinical rehabilitation exoskeleton used in hospitals globally. They are currently commercializing Eve, a personal self-balancing exoskeleton, and have recently expanded into industrial humanoid robotics with their Calvin-40 bipedal robot. Wandercraft demonstrated significant traction by raising a major €64.3 million Series D round and securing a strategic minority investment from Renault Group.